Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Haploidentical Stem Cell Transplantation With CD3/CD19 Depleted Stem Cells in Pediatric Patients With Refractory Hematological and Oncological Diseases

NCT01919866 is registered in ClinicalTrials.gov with University Children's Hospital Tuebingen as lead sponsor.

NCT NCT01919866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01919866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Haploidentical Stem Cell Transplantation With CD3/CD19 Depleted Stem Cells in Pediatric Patients With Refractory Hematological and Oncological Diseases
Lead sponsor
University Children's Hospital Tuebingen
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2004
Completion date
December 31, 2015
Enrollment
120 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemias, aplastic anemia, childhood solid tumor